Summary of STERIS plc (NYSE:STE) Ratings as of May 17, 2018

May 17, 2018 - By Sheila Anderson

STERIS plc (NYSE:STE) Corporate Logo
Big Money Sentiment decreased to 0.17 in 2017 Q4. It has change of 0.33, from 2017Q3’s 0.5. The ratio fall due to STERIS plc positioning: 4 sold and 2 reduced. 1 funds bought stakes and 0 increased stakes. Investors holded 137,131 in 2017Q3 but now own 19,649 shares or 85.67% less.
Prudential Plc owns 3,800 shs. Shine Inv Advisory Serv has invested 0.01% in STERIS plc (NYSE:STE). Hanson & Doremus Invest Management invested in 0.04% or 1,500 shs. Alphamark Advsrs Limited Liability Company holds 150 shs. Fruth Inv Mgmt holds 0.52% of its capital in STERIS plc (NYSE:STE) for 14,076 shs.

STERIS plc (NYSE:STE) Ratings Coverage

A total of 3 analysts rate STERIS (NYSE:STE) as follows: 2 “Buy”, 1 “Hold” and 0 “Sell”. Тherefore 67% are bullish. (NYSE:STE) has 3 ratings reports on May 17, 2018 according to StockzIntelligence. On Wednesday, January 3 the firm earned “Market Perform” rating by Raymond James. On Thursday, February 8 the rating was maintained by Northcoast with “Buy”. In Thursday, February 8 report KeyBanc Capital Markets maintained it with “Buy” rating and $103.0 target. Listed here are STERIS plc (NYSE:STE) PTs and latest ratings.

08/02/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $103.0 Maintain
08/02/2018 Broker: Northcoast Rating: Buy New Target: $102.0 Maintain
03/01/2018 Broker: Raymond James Old Rating: Outperform New Rating: Market Perform Old Target: $100 Downgrade

Ticker’s shares touched $103.28 during the last trading session after 0.35% change.STERIS plc has volume of 302,150 shares. Since May 17, 2017 STE has risen 32.31% and is uptrending. The stock outperformed the S&P 500 by 20.76%.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide.The firm is valued at $8.76 billion. The companyÂ’s Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.36.38 is the P/E ratio. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

There’s a significant STERIS plc (NYSE:STE) news released by Seekingalpha.com. It’s an article titled: “STERIS Plc (STE) Q4 2018 Results – Earnings Call Transcript” on May 09, 2018.

STERIS plc (NYSE:STE) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.